Physician profile
David Charles King
NPI 1043204100
$551.50
in general payments reported to CMS, 2019-2025
10 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Occupational Medicine provider received nationally (typical 2025 total: $53.66).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $138 · 2022: $67.23 · 2023: $64.46 · 2024: $123 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $126.92 | 2023-2025 | |
| Depuy Synthes Sales INC. | $115.94 | 2021 | |
| Abbvie INC. | $92.77 | 2022-2025 | |
| Lilly USA, LLC | $72.72 | 2022-2024 | Mounjaro |
| Exact Sciences Corporation | $47.50 | 2024 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $24.51 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Corcept Therapeutics | $22.43 | 2021 | |
| Amgen INC. | $16.68 | 2022 | |
| Novo Nordisk INC | $16.60 | 2025 | Wegovy |
| Glaxosmithkline, LLC. | $15.43 | 2025 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.